UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 23, 2014
Accession Number:
Submission Type:
CIK: 0001321834
Company Name: Akers Biosciences Inc
File Number: 333-190456